Pfizer Agreed To Pay $5.4 Billion in Cash for Sickle Cell Disease Drugmaker Global Blood Therapeutics (GBT.O)
Follow
0
14 views • August 09, 2022

https://gnews.org/post/p15ub7075

08/08/2022 Pfizer Inc agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics (GBT.O), as it looks to boost its rare disease treatment businesses through this purchase

Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.